The main findings from our studies are that tumour-derived CatS can transcriptionally regulate the pro-inflammatory chemokine CCL2, in a CD74-dependent manner and influence the tumour microenvironment, by altering cellular recruitment of macrophages. Here, CD74 is linked to neoplasm.